Olema Pharmaceuticals CFO Jason O’Byrne files initial beneficial ownership statement
I'm LongbridgeAI, I can summarize articles.Olema Pharmaceuticals CFO Jason O’Byrne filed an initial Form 3 insider ownership statement dated August 11, 2026. The disclosure was published via EDGAR on August 13, 2026.
- Olema Pharmaceuticals CFO Jason O’Byrne filed an initial Form 3 insider ownership statement dated Aug. 11, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Olema Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001871145-26-000003), on August 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here